T cell proliferation and adaptive immune responses are critically regulated by protein phosphatase 4

References

• Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol 2009; 27:591-619; PMID:19132916; http://dx.doi.org/10.1146/annurev.immunol.021908.132706
   PubMed Web of Science ®Google Scholar
• von Boehmer H. Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development. Adv Immunol 2004; 84:201-38; PMID:15246254; http://dx.doi.org/10.1016/S0065-2776(04)84006-9
   PubMed Web of Science ®Google Scholar
• Liao W, Lin JX, Leonard WJ. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 2013; 38:13-25; PMID:23352221; http://dx.doi.org/10.1016/j.immuni.2013.01.004.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Poffenberger MC, Chang CH, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013; 342:1242454; PMID:24115444; http://dx.doi.org/10.1126/science.1242454
   PubMedGoogle Scholar
• Wang R, Green DR. Metabolic checkpoints in activated T cells. Nat Immunol 2012; 13:907-15; PMID:22990888; http://dx.doi.org/10.1038/ni.2386.
   PubMed Web of Science ®Google Scholar
• Mills RE, Jameson JM. T cell dependence on mTOR signaling. Cell Cycle 2009; 8:545-8; PMID:19182526; http://dx.doi.org/10.4161/cc.8.4.7625
   PubMed Web of Science ®Google Scholar
• Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 2009; 9:324-37; PMID:19390566; http://dx.doi.org/10.1038/nri2546
   PubMed Web of Science ®Google Scholar
• Lage R, Dieguez C, Vidal-Puig A, Lopez M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 2008; 14:539-49; PMID:18977694; http://dx.doi.org/10.1016/j.molmed.2008.09.007
   PubMed Web of Science ®Google Scholar
• Auciello FR, Ross FA, Ikematsu N, Hardie DG. Oxidative stress activates AMPK in cultured cells primarily by increasing cellular AMP and/or ADP. FEBS Lett 2014; 588:3361-6; PMID:25084564; http://dx.doi.org/10.1016/j.febslet.2014.07.025
   PubMed Web of Science ®Google Scholar
• Blagih J, Krawczyk CM, Jones RG. LKB1 and AMPK: central regulators of lymphocyte metabolism and function. Immunol Rev 2012; 249:59-71; PMID:22889215; http://dx.doi.org/10.1111/j.1600-065X.2012.01157.x
   PubMed Web of Science ®Google Scholar
• Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011; 331:456-61; PMID:21205641; http://dx.doi.org/10.1126/science.1196371
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID:21258367; http://dx.doi.org/10.1038/ncb2152
   PubMed Web of Science ®Google Scholar
• Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, Raynaud S, Auberger P. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res 2010; 70:1042-52; PMID:20103647; http://dx.doi.org/10.1158/0008-5472.CAN-09-3537
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Ito S, Sasaki R, Asahi M, Ishida Y. Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells. Leuk Res 2013; 37:1674-9; PMID:24090995; http://dx.doi.org/10.1016/j.leukres.2013.09.010
   PubMed Web of Science ®Google Scholar
• Zou T, Yang Y, Xia F, Huang A, Gao X, Fang D, Xiong S, Zhang J. Resveratrol Inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1. PLoS One 2013; 8:e75139; PMID:24073240; http://dx.doi.org/10.1371/journal.pone.0075139
   PubMed Web of Science ®Google Scholar
• Shui JW, Hu MC, Tan TH. Conditional knockout mice reveal an essential role of protein phosphatase 4 in thymocyte development and pre-T-cell receptor signaling. Mol Cell Biol 2007; 27:79-91; PMID:17060460; http://dx.doi.org/10.1128/MCB.00799-06
   PubMed Web of Science ®Google Scholar
• Liao FH, Shui JW, Hsing EW, Hsiao WY, Lin YC, Chan YC, Tan TH, Huang CY. Protein phosphatase 4 is an essential positive regulator for Treg development, function, and protective gut immunity. Cell Biosci 2014; 4:25; PMID:24904742; http://dx.doi.org/10.1186/2045-3701-4-25
   PubMed Web of Science ®Google Scholar
• Shaltiel IA, Aprelia M, Saurin AT, Chowdhury D, Kops GJ, Voest EE, Medema RH. Distinct phosphatases antagonize the p53 response in different phases of the cell cycle. Proc Natl Acad Sci U S A 2014; 111:7313-8; PMID:24711418; http://dx.doi.org/10.1073/pnas.1322021111
   PubMed Web of Science ®Google Scholar
• Chowdhury D, Xu X, Zhong X, Ahmed F, Zhong J, Liao J, Dykxhoorn DM, Weinstock DM, Pfeifer GP, Lieberman J. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol Cell 2008; 31:33-46; PMID:18614045; http://dx.doi.org/10.1016/j.molcel.2008.05.016
   PubMed Web of Science ®Google Scholar
• Nakada S, Chen GI, Gingras AC, Durocher D. PP4 is a gamma H2AX phosphatase required for recovery from the DNA damage checkpoint. EMBO Rep 2008; 9:1019-26; PMID:18758438; http://dx.doi.org/10.1038/embor.2008.162
   PubMed Web of Science ®Google Scholar
• Lee DH, Goodarzi AA, Adelmant GO, Pan Y, Jeggo PA, Marto JA, Chowdhury D. Phosphoproteomic analysis reveals that PP4 dephosphorylates KAP-1 impacting the DNA damage response. EMBO J 2012; 31:2403-15; PMID:22491012; http://dx.doi.org/10.1038/emboj.2012.86
   PubMed Web of Science ®Google Scholar
• Lipinszki Z, Lefevre S, Savoian MS, Singleton MR, Glover DM, Przewloka MR. Centromeric binding and activity of Protein Phosphatase 4. Nat Commun 2015; 6:5894; PMID:25562660; http://dx.doi.org/10.1038/ncomms6894
   PubMed Web of Science ®Google Scholar
• Sato-Carlton A, Li X, Crawley O, Testori S, Martinez-Perez E, Sugimoto A, Carlton PM. Protein phosphatase 4 promotes chromosome pairing and synapsis, and contributes to maintaining crossover competence with increasing age. PLoS Genet 2014; 10:e1004638; PMID:25340746; http://dx.doi.org/10.1371/journal.pgen.1004638
   PubMedGoogle Scholar
• Swingle M, Ni L, Honkanen RE. Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. Methods Mol Biol 2007; 365:23-38; PMID:17200551
   PubMedGoogle Scholar
• Herzig S, Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 2000; 80:173-210; PMID:10617768
   PubMed Web of Science ®Google Scholar
• Richards FM, Milner J, Metcalfe S. Inhibition of the serine/threonine protein phosphatases PP1 and PP2A in lymphocytes: effect on mRNA levels for interleukin-2, IL-2R alpha, krox-24, p53, hsc70 and cyclophilin. Immunology 1992; 76:642-7; PMID:1328040
   PubMed Web of Science ®Google Scholar
• Grove DS, Mastro AM. Modulation of levels of a negative transcription factor for IL-2 by 12-O-tetradecanoyl phorbol-13-acetate and okadaic acid. Cytokine 1996; 8:809-16; PMID:9047076; http://dx.doi.org/10.1006/cyto.1996.0108
   PubMed Web of Science ®Google Scholar
• Samari HR, Moller MT, Holden L, Asmyhr T, Seglen PO. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins. Biochem J 2005; 386:237-44; PMID:15461583; http://dx.doi.org/10.1042/BJ20040609
   PubMed Web of Science ®Google Scholar
• Lacroix I, Lipcey C, Imbert J, Kahn-Perles B. Sp1 transcriptional activity is up-regulated by phosphatase 2A in dividing T lymphocytes. J Biol Chem 2002; 277:9598-605; PMID:11779871; http://dx.doi.org/10.1074/jbc.M111444200
   PubMed Web of Science ®Google Scholar
• Mourtada-Maarabouni M, Williams GT. Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells. Leuk Res 2009; 33:1539-51; PMID:19539371; http://dx.doi.org/10.1016/j.leukres.2009.05.013
   PubMed Web of Science ®Google Scholar
• Ohmura T, Onoue K. Stability of IL-2 mRNA in T lymphocytes is controlled by a protein kinase C-regulated mechanism. Int Immunol 1990; 2:1073-9; PMID:1964589; http://dx.doi.org/10.1093/intimm/2.11.1073
   PubMed Web of Science ®Google Scholar
• Gu Y, Rosenblatt J, Morgan DO. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 1992; 11:3995-4005; PMID:1396589
   PubMed Web of Science ®Google Scholar
• Tamas P, Hawley SA, Clarke RG, Mustard KJ, Green K, Hardie DG, Cantrell DA. Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J Exp Med 2006; 203:1665-70; PMID:16818670; http://dx.doi.org/10.1084/jem.20052469
   PubMed Web of Science ®Google Scholar
• Andris F, Leo O. AMPK in Lymphocyte Metabolism and Function. Int Rev Immunol 2014; PMID:25360847
   PubMed Web of Science ®Google Scholar
• Pollizzi KN, Powell JD. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat Rev Immunol 2014; 14:435-46; PMID:24962260; http://dx.doi.org/10.1038/nri3701
   PubMed Web of Science ®Google Scholar
• Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18:283-93; PMID:15866171; http://dx.doi.org/10.1016/j.molcel.2005.03.027
   PubMed Web of Science ®Google Scholar
• Wu Y, Song P, Xu J, Zhang M, Zou MH. Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem 2007; 282:9777-88; PMID:17255104; http://dx.doi.org/10.1074/jbc.M608310200
   PubMed Web of Science ®Google Scholar
• Moore F, Weekes J, Hardie DG. Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase. A sensitive mechanism to protect the cell against ATP depletion. Eur J Biochem 1991; 199:691-7; PMID:1678349; http://dx.doi.org/10.1111/j.1432-1033.1991.tb16172.x
   PubMedGoogle Scholar
• Wang L, Brautigan DL. alpha-SNAP inhibits AMPK signaling to reduce mitochondrial biogenesis and dephosphorylates Thr172 in AMPKalpha in vitro. Nat Commun 2013; 4:1559; PMID:23463002; http://dx.doi.org/10.1038/ncomms2565
   PubMed Web of Science ®Google Scholar
• Liang X, Wang P, Gao Q, Tao X. Exogenous activation of LKB1/AMPK signaling induces G(1) arrest in cells with endogenous LKB1 expression. Mol Med Rep 2014; 9:1019-24; PMID:24469340
   PubMed Web of Science ®Google Scholar
• Cai X, Hu X, Cai B, Wang Q, Li Y, Tan X, Hu H, Chen X, Huang J, Cheng J, et al. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo. Oncol Rep 2013; 30:2449-57; PMID:24008375
   PubMed Web of Science ®Google Scholar
• Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006; 7:667-77; PMID:16921403; http://dx.doi.org/10.1038/nrm1987
   PubMed Web of Science ®Google Scholar
• Valdor R, Macian F. Induction and stability of the anergic phenotype in T cells. Semin Immunol 2013; 25:313-20; PMID:24211041; http://dx.doi.org/10.1016/j.smim.2013.10.010
   PubMed Web of Science ®Google Scholar
• Zheng Y, Delgoffe GM, Meyer CF, Chan W, Powell JD. Anergic T cells are metabolically anergic. J Immunol 2009; 183:6095-101; PMID:19841171; http://dx.doi.org/10.4049/jimmunol.0803510
   PubMed Web of Science ®Google Scholar
• Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Perez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001; 15:763-74; PMID:11728338; http://dx.doi.org/10.1016/S1074-7613(01)00227-8
   PubMed Web of Science ®Google Scholar
• Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68:869-77; PMID:1547488; http://dx.doi.org/10.1016/0092-8674(92)90030-G
   PubMed Web of Science ®Google Scholar
• He J, Nguyen AT, Zhang Y. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia. Blood 2011; 117:3869-80; PMID:21310926; http://dx.doi.org/10.1182/blood-2010-10-312736
   PubMed Web of Science ®Google Scholar
• Hedin KE, Bell MP, Kalli KR, Huntoon CJ, Sharp BM, McKean DJ. Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J Immunol 1997; 159:5431-40; PMID:9548483
   PubMed Web of Science ®Google Scholar
• Macian F, Garcia-Rodriguez C, Rao A. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 2000; 19:4783-95; PMID:10970869; http://dx.doi.org/10.1093/emboj/19.17.4783
   PubMed Web of Science ®Google Scholar